[
  {
    "ts": "2026-01-02T11:00:00+00:00",
    "headline": "Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 7:30 am Pacific Time.",
    "url": "https://finance.yahoo.com/news/haemonetics-present-44th-annual-j-110000098.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "48a1c487-fa0f-37c2-bb9d-eb7e88497fa2",
      "content": {
        "id": "48a1c487-fa0f-37c2-bb9d-eb7e88497fa2",
        "contentType": "STORY",
        "title": "Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 7:30 am Pacific Time.",
        "pubDate": "2026-01-02T11:00:00Z",
        "displayTime": "2026-01-02T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/512e211fe9b209e3384f3b709e0c679c",
          "originalWidth": 400,
          "originalHeight": 93,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HSX2Y0Dk4KJJnHMuQxkCJw--~B/aD05Mzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/512e211fe9b209e3384f3b709e0c679c.cf.webp",
              "width": 400,
              "height": 93,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I9o0xCFWyplHBs3UOPNJAw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/512e211fe9b209e3384f3b709e0c679c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/haemonetics-present-44th-annual-j-110000098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/haemonetics-present-44th-annual-j-110000098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HAE"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T12:00:00+00:00",
    "headline": "Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 3:00 p.m. PT / 6:00 p.m. ET.",
    "url": "https://finance.yahoo.com/news/insmed-present-44th-annual-j-120000623.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "3f937691-e0a2-392c-928c-42869d9e6cba",
      "content": {
        "id": "3f937691-e0a2-392c-928c-42869d9e6cba",
        "contentType": "STORY",
        "title": "Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 3:00 p.m. PT / 6:00 p.m. ET.",
        "pubDate": "2026-01-02T12:00:00Z",
        "displayTime": "2026-01-02T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/af9dece69798605e068fb46028512647",
          "originalWidth": 400,
          "originalHeight": 186,
          "caption": "Insmed-Logo-Purple (PRNewsfoto/Insmed Incorporated)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kvP0fWnQAqRVnsbwTDuWSA--~B/aD0xODY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/af9dece69798605e068fb46028512647.cf.webp",
              "width": 400,
              "height": 186,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_5Pzk70xKAOz18v4cwe7sw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/af9dece69798605e068fb46028512647.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/insmed-present-44th-annual-j-120000623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/insmed-present-44th-annual-j-120000623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INSM"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T11:59:00+00:00",
    "headline": "Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference",
    "summary": "PRINCETON, N.J., January 02, 2026--Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare Conference",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-j-115900859.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "66988d36-b9bc-30e5-b61d-346cbad00eb9",
      "content": {
        "id": "66988d36-b9bc-30e5-b61d-346cbad00eb9",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference",
        "description": "",
        "summary": "PRINCETON, N.J., January 02, 2026--Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare Conference",
        "pubDate": "2026-01-02T11:59:00Z",
        "displayTime": "2026-01-02T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/38f272e4ec232bf2169bca2d0e8bf2dc",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSzgQRatSjYytrS9PEKnog--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/38f272e4ec232bf2169bca2d0e8bf2dc.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oOvXraeNaQC5aBPujuC0Gw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/38f272e4ec232bf2169bca2d0e8bf2dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-j-115900859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-j-115900859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T13:00:00+00:00",
    "headline": "Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results",
    "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in San Francisco. Mike Mahoney, chairman and chief executive officer, Jon Monson, executive vice president and chief financial officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 40-minute question-and-answer session with the host analyst. The session will begin at approximately 9:00 a.m. PT / 12:00",
    "url": "https://finance.yahoo.com/news/boston-scientific-announces-participation-j-130000046.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "f54d7c7a-9821-3edf-973a-f92c95c4e721",
      "content": {
        "id": "f54d7c7a-9821-3edf-973a-f92c95c4e721",
        "contentType": "STORY",
        "title": "Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results",
        "description": "",
        "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in San Francisco. Mike Mahoney, chairman and chief executive officer, Jon Monson, executive vice president and chief financial officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 40-minute question-and-answer session with the host analyst. The session will begin at approximately 9:00 a.m. PT / 12:00",
        "pubDate": "2026-01-02T13:00:00Z",
        "displayTime": "2026-01-02T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888",
          "originalWidth": 400,
          "originalHeight": 209,
          "caption": "Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bqyalFkM.p2vF1LWkaMoDA--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 400,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oi.RxhAOmrA0KHLwcormRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-participation-j-130000046.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-participation-j-130000046.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T14:10:23+00:00",
    "headline": "JPMorgan Boosts Rating on Recursion Pharmaceuticals (RXRX) Amid AI-Driven Drug Pipeline",
    "summary": "Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral to an Overweight rating, boosting the price target to $11 from $10. The change follows the solid results of Recursion’s MEK 1/2 inhibitor, REC-4881, which showed potent effectiveness […]",
    "url": "https://finance.yahoo.com/news/jpmorgan-boosts-rating-recursion-pharmaceuticals-141023713.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a05fe9d7-6e40-3e48-98c0-80656efdc25d",
      "content": {
        "id": "a05fe9d7-6e40-3e48-98c0-80656efdc25d",
        "contentType": "STORY",
        "title": "JPMorgan Boosts Rating on Recursion Pharmaceuticals (RXRX) Amid AI-Driven Drug Pipeline",
        "description": "",
        "summary": "Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral to an Overweight rating, boosting the price target to $11 from $10. The change follows the solid results of Recursion’s MEK 1/2 inhibitor, REC-4881, which showed potent effectiveness […]",
        "pubDate": "2026-01-02T14:10:23Z",
        "displayTime": "2026-01-02T14:10:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66",
          "originalWidth": 1920,
          "originalHeight": 1282,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IdJAH7xlT5z0Usubd4WzNQ--~B/aD0xMjgyO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66.cf.webp",
              "width": 1920,
              "height": 1282,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NdySNIhfoJQSPxvzs_Yikg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-boosts-rating-recursion-pharmaceuticals-141023713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-boosts-rating-recursion-pharmaceuticals-141023713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RXRX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T13:34:38+00:00",
    "headline": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
    "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
    "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
      "content": {
        "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
        "contentType": "STORY",
        "title": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
        "description": "",
        "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
        "pubDate": "2026-01-02T13:34:38Z",
        "displayTime": "2026-01-02T13:34:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wallstreetsign.jpg - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lI5cIjBjU5eubUz1M.E4aA--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pEfwAFBugUgkoc.pTwU_Jw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T18:19:00+00:00",
    "headline": "The Market Was Calm to End 2025. January Will Bring a Rude Awakening.",
    "summary": "With stock prices near record levels, the easy ride they’ve enjoyed will be a lot tougher in 2026. Any slight disappointment is bound to cause prices to drop and volatility to spike.",
    "url": "https://www.barrons.com/articles/market-calm-end-2025-january-rude-awakening-8a99198a?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e4632352-e1ec-3f1b-87b8-b26f64aa1c9a",
      "content": {
        "id": "e4632352-e1ec-3f1b-87b8-b26f64aa1c9a",
        "contentType": "STORY",
        "title": "The Market Was Calm to End 2025. January Will Bring a Rude Awakening.",
        "description": "",
        "summary": "With stock prices near record levels, the easy ride they’ve enjoyed will be a lot tougher in 2026. Any slight disappointment is bound to cause prices to drop and volatility to spike.",
        "pubDate": "2026-01-02T18:19:00Z",
        "displayTime": "2026-01-02T18:19:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e4632352-e1ec-3f1b-87b8-b26f64aa1c9a/the-market-was-calm-to-end.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/654b580ef676242e16ec8dd4d75e7472",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e_In.8a97HrKA2HiCWO9gg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/654b580ef676242e16ec8dd4d75e7472.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tFLLAGgrlO5TmV9dKvMv9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/654b580ef676242e16ec8dd4d75e7472.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/market-calm-end-2025-january-rude-awakening-8a99198a?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T21:05:00+00:00",
    "headline": "RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference",
    "summary": "ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: ht",
    "url": "https://finance.yahoo.com/news/rxsight-inc-present-j-p-210500517.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "1fb0c473-894f-3067-a540-48a6e864e602",
      "content": {
        "id": "1fb0c473-894f-3067-a540-48a6e864e602",
        "contentType": "STORY",
        "title": "RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: ht",
        "pubDate": "2026-01-02T21:05:00Z",
        "displayTime": "2026-01-02T21:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/172fe70c9dca998cd3c075e571742475",
          "originalWidth": 478,
          "originalHeight": 147,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nLsxzSPU_DZmAZQrT5cFyg--~B/aD0xNDc7dz00Nzg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/172fe70c9dca998cd3c075e571742475.cf.webp",
              "width": 478,
              "height": 147,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4Lf5LEc_RO.TAx5_XxFIGQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/172fe70c9dca998cd3c075e571742475.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rxsight-inc-present-j-p-210500517.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rxsight-inc-present-j-p-210500517.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RXST"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T23:52:32+00:00",
    "headline": "JPMorgan Sees Clearer Growth Path for RTX Heading into 2026",
    "summary": "RTX Corporation (NYSE:RTX) is included among the 20 Best Performing Dividend Stocks in 2025. On December 19, JPMorgan analyst Seth Seifman raised the firm’s price target on RTX Corporation (NYSE:RTX) to $200 from $195 and kept an Overweight rating on the shares as part of its aerospace and defense outlook for 2026. The outlook for […]",
    "url": "https://finance.yahoo.com/news/jpmorgan-sees-clearer-growth-path-235232503.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "927471cf-6765-3246-a303-a6554516c80b",
      "content": {
        "id": "927471cf-6765-3246-a303-a6554516c80b",
        "contentType": "STORY",
        "title": "JPMorgan Sees Clearer Growth Path for RTX Heading into 2026",
        "description": "",
        "summary": "RTX Corporation (NYSE:RTX) is included among the 20 Best Performing Dividend Stocks in 2025. On December 19, JPMorgan analyst Seth Seifman raised the firm’s price target on RTX Corporation (NYSE:RTX) to $200 from $195 and kept an Overweight rating on the shares as part of its aerospace and defense outlook for 2026. The outlook for […]",
        "pubDate": "2026-01-02T23:52:32Z",
        "displayTime": "2026-01-02T23:52:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5",
          "originalWidth": 1920,
          "originalHeight": 1297,
          "caption": "JPMorgan Sees Clearer Growth Path for RTX Heading into 2026",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSxIzcY_BXa.RVyX155p6g--~B/aD0xMjk3O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5.cf.webp",
              "width": 1920,
              "height": 1297,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BN3qCh8k0fiWexwcg2uacA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-sees-clearer-growth-path-235232503.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-sees-clearer-growth-path-235232503.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RTX"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "LMT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T22:45:06+00:00",
    "headline": "JPMorgan Chase & Co. (JPM) Exceeds Market Returns: Some Facts to Consider",
    "summary": "The latest trading day saw JPMorgan Chase & Co. (JPM) settling at $325.48, representing a +1.01% change from its previous close.",
    "url": "https://finance.yahoo.com/news/jpmorgan-chase-co-jpm-exceeds-224506022.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "cf08f2fb-b612-32c3-82f2-2451b5ff7a4e",
      "content": {
        "id": "cf08f2fb-b612-32c3-82f2-2451b5ff7a4e",
        "contentType": "STORY",
        "title": "JPMorgan Chase & Co. (JPM) Exceeds Market Returns: Some Facts to Consider",
        "description": "",
        "summary": "The latest trading day saw JPMorgan Chase & Co. (JPM) settling at $325.48, representing a +1.01% change from its previous close.",
        "pubDate": "2026-01-02T22:45:06Z",
        "displayTime": "2026-01-02T22:45:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83",
          "originalWidth": 900,
          "originalHeight": 633,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7Y5JgUaFZFuBLe5dh5H4ng--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83.cf.webp",
              "width": 900,
              "height": 633,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IGtpvtZ0OkzJMDD0I3exBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chase-co-jpm-exceeds-224506022.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-chase-co-jpm-exceeds-224506022.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JPM"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T20:41:00+00:00",
    "headline": "Beyond the Santa Claus Rally—5 Quality Stocks to Buy in 2026",
    "summary": "There may not be a Santa Claus rally, but 2026 still looks bullish; here are five high-quality stocks that could benefit from earnings growth and lower rates",
    "url": "https://www.marketbeat.com/stock-ideas/beyond-the-santa-claus-rally5-quality-stocks-to-buy-in-2026/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "e3db6109-1af4-3fc0-b33a-372f231c8060",
      "content": {
        "id": "e3db6109-1af4-3fc0-b33a-372f231c8060",
        "contentType": "STORY",
        "title": "Beyond the Santa Claus Rally—5 Quality Stocks to Buy in 2026",
        "description": "",
        "summary": "There may not be a Santa Claus rally, but 2026 still looks bullish; here are five high-quality stocks that could benefit from earnings growth and lower rates",
        "pubDate": "2026-01-02T20:41:00Z",
        "displayTime": "2026-01-02T20:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/3438f114ce359ea160f7da9586b9c123",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Rising market chart with Santa rally motif on a desk beside a 2026 calendar, signaling optimism for stock markets.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbLM4.U_vacTx4LCJ1EoHQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/3438f114ce359ea160f7da9586b9c123.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SXkPsFCTbeQk7n4cFm4Mzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/3438f114ce359ea160f7da9586b9c123.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/stock-ideas/beyond-the-santa-claus-rally5-quality-stocks-to-buy-in-2026/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beyond-santa-claus-rally-5-204100880.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LULU"
            },
            {
              "symbol": "DE"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]